International Assets Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
SAM
International Assets Investment Management's BMY Position: Q2 2026 in Review
International Assets Investment Management increased its Bristol-Myers Squibb (BMY) stake by 8.4% in Q2 2026, buying an estimated $151K and bringing the position to 33,993 shares worth $1.92M. The position accounts for 0.11% of the portfolio, ranked #166.
International Assets Investment Management first reported a position in BMY in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.65M in Q1 2025. 1,360 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- International Assets Investment Management held 33,993 shares of Bristol-Myers Squibb worth $1.92M as of Q2 2026.
- International Assets Investment Management bought 2,621 Bristol-Myers Squibb shares in Q2 2026, an estimated $151K.
- Bristol-Myers Squibb made up 0.11% of International Assets Investment Management's portfolio in Q2 2026, its #166 holding.
- International Assets Investment Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 26 quarters since.
- International Assets Investment Management's Bristol-Myers Squibb position peaked at $2.65M in Q1 2025.
- 1,360 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.